U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190291190291Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNo Results AvailableLeukemia|LymphomaBiological: lumiliximabhttps://ClinicalTrials.gov/show/NCT00058396
190292190292Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With MedulloblastomaActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: cisplatin|Drug: lomustine|Drug: vincristine sulfate|Procedure: adjuvant therapy|Radiation: iodine I 131 monoclonal antibody 3F8|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00058370
190293190293Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After SurgeryCompletedNo Results AvailablePain|Unspecified Adult Solid Tumor, Protocol SpecificDrug: lidocainehttps://ClinicalTrials.gov/show/NCT00058357
190294190294Epoetin Alfa in Treating Anemia in Patients With Solid TumorsCompletedNo Results AvailableAnemia|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Precancerous Condition|Unspecified Adult Solid Tumor, Protocol SpecificBiological: epoetin alfahttps://ClinicalTrials.gov/show/NCT00058331
190295190295S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerCompletedNo Results AvailableKidney CancerDrug: capecitabine|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00058318
190296190296Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell TransplantationCompletedNo Results AvailableExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|RDrug: bryostatin 1|Drug: vincristine sulfate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00058305
190297190297Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: filgrastim|Biological: rituximab|Drug: Carmustine|Drug: cytarabine|Drug: etoposide|Drug: melphalan|Procedure: peripheral blood stem cell transplantation|Radiation: yttrium Y 90 ibritumomab tiuxetanhttps://ClinicalTrials.gov/show/NCT00058292
190298190298Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)Biological: aldesleukin|Biological: ipilimumabhttps://ClinicalTrials.gov/show/NCT00058279
190299190299Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical ProstatectomyTerminatedNo Results AvailableProstate CancerDietary Supplement: genistein|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00058266
190300190300Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNo Results AvailableRecurrent Prostate Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: tanespimycin|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00058253
190301190301Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNo Results AvailableB-cell Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Waldenström MacroglobulinemiaDrug: alvocidibhttps://ClinicalTrials.gov/show/NCT00058240
190302190302Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaCompletedNo Results AvailableB-cell Chronic Lymphocytic Leukemia|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic LDrug: alvocidib|Drug: fludarabine phosphate|Biological: rituximab|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00058227
190303190303Perifosine in Treating Patients With Recurrent Prostate CancerTerminatedHas ResultsAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate CancerDrug: perifosine|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00058214
190304190304Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calcium|Other: clinical observationhttps://ClinicalTrials.gov/show/NCT00058201
190305190305Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen DeprivationActive, not recruitingNo Results AvailableOsteoporosis|Prostate CancerDietary Supplement: cholecalciferol|Drug: calcium gluconate|Drug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00058188
190306190306Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: gemcitabine hydrochloride|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00058149
190307190307Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: poly ICLChttps://ClinicalTrials.gov/show/NCT00058123
190308190308Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNo Results AvailableAdult Giant Cell Glioblastoma|Adult Glioblastoma|Adult GliosarcomaDrug: tipifarnib|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00058097
190309190309Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate CancerCompletedNo Results AvailableAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage IV Prostate CancerDrug: ixabepilone|Drug: mitoxantrone hydrochloride|Drug: prednisonehttps://ClinicalTrials.gov/show/NCT00058084
190310190310Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for CancerCompletedNo Results AvailableGestational Trophoblastic Tumor|Neurotoxicity|Peripheral Neuropathy|Unspecified Adult Solid Tumor, Protocol SpecificDrug: amifostine trihydratehttps://ClinicalTrials.gov/show/NCT00058071
190311190311Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast CancerCompletedNo Results AvailableBreast CancerProcedure: magnetic resonance imaging|Radiation: gadopentetate dimegluminehttps://ClinicalTrials.gov/show/NCT00058058
190312190312Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related CancerCompletedNo Results AvailableLymphomaBiological: aldesleukin|Biological: recombinant human stem cell factorhttps://ClinicalTrials.gov/show/NCT00058045
190313190313CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal WomenCompletedNo Results AvailableOvarian CancerOther: screening questionnaire administration|Procedure: annual screeninghttps://ClinicalTrials.gov/show/NCT00058032
190314190314Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedHas ResultsAnaplastic Large Cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell LymphomaDrug: ixabepilonehttps://ClinicalTrials.gov/show/NCT00058019
190315190315Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNo Results AvailableHead and Neck Cancer|Lung CancerDrug: celecoxib|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00058006
190316190316Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNo Results AvailableBreast CancerBiological: trastuzumab|Drug: exemestanehttps://ClinicalTrials.gov/show/NCT00057993
190317190317Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNo Results AvailableLiver CancerDrug: celecoxib|Drug: epirubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00057980
190318190318Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary SyndromeActive, not recruitingNo Results AvailableLymphomaBiological: alemtuzumabhttps://ClinicalTrials.gov/show/NCT00057967
190319190319Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedHas ResultsLymphomaProcedure: Extracorporeal Photopheresis|Drug: Pentostatin|Radiation: Total body irradiation (TBI)|Procedure: Allogeneic bone marrow transplantation|Drug: Cyclosporin (CSA)|Drug: Mycophenolate mofetil (MMF)|Drug: Methotrexate (MTX)https://ClinicalTrials.gov/show/NCT00057954
190320190320Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast CancerCompletedHas ResultsEstrogen Receptor-positive Breast Cancer|Progesterone Receptor-positive Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerDrug: anastrozole|Drug: gefitinib|Drug: fulvestrant|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00057941

* Görseller ve İçerik tekif hakkına sahip olabilir